FauciA.S.Current issues in developing a strategy for dealing with the acquired immunodeficiency syndrome.Proc Natl Acad Sci, U.S.A.1986; 83: 9278–9283.
2.
U.S. Public Health Service.Coolfront Report: A PHS Plan for Prevention and Control of AIDS and the AIDS virus.Public Health Rep1986; 101: 341–348.
3.
CoxD.Short term prediction of HIV infection and AIDS in England and Wales. Report of a working group. HMSOLondon1988.
4.
AndersonR.M., MayR.M.Epidemiological Parameters of HIV Transmission.Nature1988; 333: 514–519.
5.
RedfieldR.R., BurkeD.S.HIV infection: The clinical picture.Scientific American, October1988; 70–78.
6.
SearleJ.AIDS virus infection; prognosis and transmission.J Roy Soc Med1985; 78: 613–615.
7.
Communicable Diseases Intelligence. Bulletins 87/23 (23 Nov. 1987) and 88/24 (5 Dec. 1988). Dept. of Health, A.C.T.,Australia.
8.
IshamV.Mathematical modelling of the Transmission Dynamics of HIV Infection and AIDS; a Review.J Roy Stat Soc (A)1988; 151, 1: 5–30.
9.
MedleyG.F., AndersonR.M.Incubation period of AIDS in patients infected via blood transfusion.Nature1987; 328: 719–721.
10.
AndersonR.M.The epidemiology of HIV infection: Variable incubation plus infectious periods and heterogeniety in sexual activity.J Roy Stat Soc (A)1988; 151, 1: 66–93.
11.
AIDS in the U.K.and Worldwide. Notes and News.Lancet1989; Jan 21: 173.
12.
GojoboriT., YokoyamaS.Rates of evolution of the retroviral oncogene of Moloney murine sarcoma virus and of its cellular homologues.Proc Natl Acad Sci, U.S.A.1985; 822: 4198–4201.
13.
LevyJ.A.Mysteries of HIV: Challenges for therapy and prevention.Nature1988; 333: 519–522.
14.
TschachlerE., GrobV.Epidermal Langerhans cells: a target for HTLV-III/LAV infection.J Invest Dermatol1987; 88: 233–237.
15.
KayL.A.Immunology of human skin and susceptibility to HIV infection.Lancet1987; July 18: 155 (letter).
16.
HirschM.S., SchooleyR.T.Resistance to antiviral drugs: The end of innocence.N Engl J Med1989; 320, 5: 313–314 (Editorial).
17.
BachM.C.Failure of Zidovudine to maintain remission in patients with AIDS.N Engl J Med1989; 594–5 (letter).
18.
TakedaA., TuazonC.A., EnnisF.A.Antibody-Enhanced Infection by HIV-1 via Fc Receptor-Mediated Entry.Science1988; 242: 580–583.
19.
Van GriensvenG.J.P., de VroomeE.M.M.Changes in sexual behaviour and the fall in incidence of HIV infection among homosexual men.BMJ1989; 298: 218–221.
20.
EvansB.A., McLeanK.A.Trends in sexual behaviour and risk factors for HIV infection among homosexual men, 1984–7.BMJ1989; 298: 215–218.
21.
LaurianY., PeynetJ., VerroustF.HIV infection in sexual partners of HIV-seropositive patients with haemophilia.N Engl J Med1989; 320, 3: 183.
22.
AhluwaliaI.B.Epidemiology of AIDS. In AIDS, a health care management response.Blanchet KD Aspen, Maryland1988; 3: 46.
23.
European Study Group.Risk factors for male to female transmission of HIV.BMJ1989; 298: 411–414.
24.
StewartG.J., TylerJ.P.P.Transmission of human T-cell lymphotropic virus type III (HTLV-III) by artificial insemination by donor.Lancet1985; Sept. 14: 581–584.
25.
JonesM.E., SolomonP.J.A note on the concept of the incubation period in HIV infection.J Roy Stat Soc (A)1988; 151, 1: 40–42.
26.
SalzbergA.M., DolinsS.L., RunserR.H.Transmission of HIV by blood transfusion.N Engl J Med1988; 319: 515.
27.
SalzbergA.M., DolinsS.L.More on transmission of HIV by blood transfusion.N Engl J Med1989–320, 7: 463 (letter).
28.
BarnesD.M.Health Workers and AIDS: Questions Persist.Science1988; 241: 161–162.
29.
BendittJ.Report from Stockholm.Scientific American Aug.1988; 6(Editorial).
30.
GrabauJ.C., MorseD.L.Seropositivity for HIV at alternate sites.JAMA1988; Dec. 2: 318 (letter).
31.
HoffR., BerardiV.P.Seroprevalence of human immunodeficiency virus among childbearing women.N Engl J Med1988; 318: 525–530.
32.
KellenG.D.Unrecognized human immunodeficiency virus infection in emergency department patients.N Engl J Med1988; 318, 5: 1645–1650.